{"url_path":"/sec/glsi/10-k/2026/item-2","section_key":"item-2","section_title":"Item 2 PROPERTIES**","topic":"sec","document":{"doc_type":"10-K","doc_date":"2026-06-01","source_url":"https://www.sec.gov/Archives/edgar/data/1799788/0001493152-26-026651-index.html","accession_number":"0001493152-26-026651","cik":"0001799788","ticker":"GLSI","issuer_name":"Greenwich LifeSciences, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1799788/0001493152-26-026651-index.html","primary_entity_key":"0001799788","primary_entity_name":"Greenwich LifeSciences, Inc."},"word_count":17,"has_tables":true,"body_markdown":"**ITEM\n2. PROPERTIES**\n\n \n\nWe\nsublease a facility to support our clinical trial operations and research and development."}